Free Trial

Owens & Minor (NYSE:OMI) Posts Earnings Results, Beats Expectations By $0.01 EPS

Owens & Minor logo with Medical background

Owens & Minor (NYSE:OMI - Get Free Report) issued its quarterly earnings results on Monday. The company reported $0.42 earnings per share for the quarter, topping analysts' consensus estimates of $0.41 by $0.01, Briefing.com reports. The company had revenue of $2.72 billion for the quarter, compared to the consensus estimate of $2.68 billion. Owens & Minor had a negative net margin of 0.40% and a positive return on equity of 14.66%. The firm's quarterly revenue was up 5.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.44 EPS. Owens & Minor updated its FY 2024 guidance to 1.450-1.550 EPS and its FY24 guidance to $1.45-1.55 EPS.

Owens & Minor Trading Down 1.8 %

Shares of NYSE:OMI traded down $0.22 during trading on Tuesday, reaching $11.78. 1,273,269 shares of the company traded hands, compared to its average volume of 834,960. The firm has a market capitalization of $908.24 million, a price-to-earnings ratio of -21.04, a P/E/G ratio of 0.43 and a beta of 0.41. Owens & Minor has a 52-week low of $11.42 and a 52-week high of $28.35. The company has a current ratio of 1.09, a quick ratio of 0.51 and a debt-to-equity ratio of 2.17. The business's fifty day moving average is $14.54 and its 200-day moving average is $16.19.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Robert W. Baird dropped their price objective on shares of Owens & Minor from $19.00 to $14.00 and set a "neutral" rating on the stock in a report on Tuesday. Barclays dropped their price objective on shares of Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating on the stock in a report on Tuesday. JPMorgan Chase & Co. decreased their price target on Owens & Minor from $22.00 to $18.00 and set an "underweight" rating on the stock in a research report on Wednesday, August 21st. StockNews.com cut Owens & Minor from a "buy" rating to a "hold" rating in a research report on Monday, August 26th. Finally, Citigroup decreased their price target on Owens & Minor from $21.00 to $18.50 and set a "buy" rating on the stock in a research report on Tuesday. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, Owens & Minor presently has an average rating of "Hold" and a consensus target price of $18.50.

Read Our Latest Stock Report on OMI

Owens & Minor Company Profile

(Get Free Report)

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.

Featured Articles

Earnings History for Owens & Minor (NYSE:OMI)

Should you invest $1,000 in Owens & Minor right now?

Before you consider Owens & Minor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.

While Owens & Minor currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines